Joseph Greene, MD
Orthopaedic Surgery · Louisville, KYNPI 1356469696
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $481,113 of the $580,545 with a category attached, or 82.9%. 27 manufacturers reported payments, led by Medacta USA, Inc. at 53.1% of the total. Among orthopaedic surgery clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 527 payments — averaging $1101.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$308K
- Zimmer Biomet$173K
- Globus Medical$57K
- Smith+Nephew$35K
- Medtronic$3K
- Heraeus Medical, LLC.$1K
- plus $2K from 21 others
Across 2 payments — averaging $1917.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$4K
What the payments were for
- Royalty or licence$480%
- Consulting fees$481,11383%
- Speaking & faculty fees$30,1305%
- Travel & lodging$57,08710%
- Food & beverage$11,9022%
- Education$2650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 189 | $308,446 |
| Zimmer Biomet | 194 | $173,259 |
| Globus Medical | 58 | $57,056 |
| Smith+Nephew | 46 | $35,395 |
| Medtronic(2 entities) | 4 | $2,566 |
| Heraeus Medical, LLC. | 1 | $1,400 |
| Arthrex | 1 | $1,000 |
| Stryker | 6 | $303 |
| Pacira Therapeutics, Inc. | 6 | $290 |
| Osteoremedies, LLC | 1 | $156 |
| KCI USA, Inc. | 2 | $137 |
| Encore Medical, LP | 1 | $130 |
| Integrity Orthopaedics, Inc. | 1 | $75 |
| Heron Therapeutics, Inc. | 1 | $62 |
| Vertex | 2 | $43 |
| Dynasplint Systems Inc. | 1 | $38 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Innovation Technologies Inc | 1 | $30 |
| Bioventus LLC | 1 | $20 |
| Eagle Pharmaceuticals, Inc. | 1 | $19 |
| Acacia Pharma Inc | 2 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Flowonix Medical Incorporated | 1 | $12 |
| Alpha Orthopedic Systems | 1 | $11 |
| Amgen | 1 | $11 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Orthofix Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$151,970
- Persona$128,908
- GMK Sphere Revision System$78,466
- Persona Revision$40,547
- Oxford$31,566
- Journey II$25,743
- Unicondylar Knee System$25,410
- GMK REVISION$23,004
- Journey II CR$21,936
- MYKNEE$19,940
- Fuzion$16,356
- Journey II BCS$16,256
- AMISTEM$15,278
- Unicondylar Knee Artho$14,797
- Journey Uni$7,988
- BIRMINGHAM HIP$7,600
- LEGION TKS$7,350
- PD-Knee-New Product$7,250
- Joint Arthoplasty$6,506
- MOTO UNI$5,950
How this compares
$580,545 in reported general payments places this provider in the 95th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 352 | $10,387 |
| Tranexamic Acid | 399 | $10,149 |
| XareltoRivaroxaban | 21 | $7,826 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 484 | $6,297 |
| Ondansetron Hcl | 406 | $2,351 |
| Mupirocin | 367 | $1,792 |
| Meloxicam | 129 | $920 |
| Diclofenac Sodium | 53 | $599 |
| Oxycodone Hcl | 51 | $536 |
| Gabapentin | 19 | $529 |
| Doxycycline Hyclate | 112 | $493 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $375 |
| Methylprednisolone | 35 | $187 |
| Hydromorphone Hcl | 25 | $135 |
| Tramadol Hcl | 43 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $37 | $7,82621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 322 orthopaedic surgery providers in Kentucky.
Other orthopaedic surgery in Louisville
- Arthur MalkaniLouisville$9.6M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- George QuillLouisville$304K
- Rodolfo Zamora RendichLouisville$292K
- Richard SweetLouisville$238K
- Frank BonnarensLouisville$146K
- Ryan EadsLouisville$99K
- Kevin HarreldLouisville$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.